Research Progress of SN38 Drug Delivery System in Cancer Treatment.

Authors:
Qi QR; Tian H; Yue BS; Zhai BT; Zhao F.

Journal:
Int J Nanomedicine

Publication Year: 2024

DOI:
10.2147/IJN.S435407

PMCID:
PMC10826519

PMID:
38293612

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Int J Nanomedicine

Abbreviation: Int J Nanomedicine

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nanotechnology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Accumulation of Iron Oxide-Based Contrast Agents in Rabbit Atherosclerotic Plaques in Relation to P…
Sekita A; Unterweger H; Berg S and 11 more (2024) - Transparency Score: 3/6
Advances in Ferroptosis-Inducing Agents by Targeted Delivery System in Cancer Therapy.
Xiang D; Zhou L; Yang R and 5 more (2024) - Transparency Score: 3/6
Anticancer Mechanisms and Potential Anticancer Applications of Antimicrobial Peptides and Their Nan…
Dong Z; Zhang X; Zhang Q and 4 more (2024) - Transparency Score: 3/6
Anti-Cancer Potency of Copper-Doped Carbon Quantum Dots Against Breast Cancer Progression.
Wang M; Lan S; Zhang W and 7 more (2024) - Transparency Score: 3/6
Anticipation and Verification of Dendrobium-Derived Nanovesicles for Skin Wound Healing Targets, Pr…
Tu J; Jiang F; Fang J and 6 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors declare no potential conflicts of interest in this work."

Evidence found in paper:

"This research was supported by grants from the National Natural Science Foundation of China (grant No. 82204935), Natural Science Basic Research Program Project of Shaanxi Province (grant No. 2022JQ-917, 2022JQ-932), Scientific Research Project of Xi’an Administration of Traditional Chinese Medicine (grant No. SZY202103), Scientific Research Project of Xi’an Municipal Health Commission (grant No. 2022yb01), and Open Project of Shaanxi Key Laboratory of Chinese Medicine Fundamentals and New Drugs Research (grant No. KF2201)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025